[HTML][HTML] Isolation and retrieval of circulating tumor cells using centrifugal forces

HW Hou, ME Warkiani, BL Khoo, ZR Li, RA Soo… - Scientific reports, 2013 - nature.com
Presence and frequency of rare circulating tumor cells (CTCs) in bloodstreams of cancer
patients are pivotal to early cancer detection and treatment monitoring. Here, we use a spiral …

Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

A Drilon, V Subbiah, O Gautschi, P Tomasini… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Selpercatinib, a first-in-class, highly selective, and potent CNS-active RET kinase
inhibitor, is currently approved for the treatment of patients with RET fusion–positive non …

[HTML][HTML] Advances in systemic treatment for nasopharyngeal carcinoma

WL Tan, EH Tan, DWT Lim, QS Ng… - Chinese clinical …, 2016 - cco.amegroups.org
Nasopharyngeal carcinoma (NPC) is a unique disease endemic in Asia. It is etiologically
linked to the Epstein-Barr virus and is both radio-and chemo-sensitive. While radiotherapy …

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous …

YL Wu, Y Cheng, J Zhou, S Lu, Y Zhang… - The Lancet …, 2020 - thelancet.com
Background We evaluated the efficacy and safety of tepotinib, a potent and highly selective
oral MET inhibitor, plus gefitinib in patients with epidermal growth factor receptor (EGFR) …

[HTML][HTML] Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells

ME Warkiani, G Guan, KB Luan, WC Lee, AAS Bhagat… - Lab on a Chip, 2014 - pubs.rsc.org
The enumeration and characterization of circulating tumor cells (CTCs), found in the
peripheral blood of cancer patients, provide a potentially accessible source for cancer …

Genomic landscape of lung adenocarcinoma in East Asians

J Chen, H Yang, ASM Teo, LB Amer, FG Sherbaf… - Nature …, 2020 - nature.com
Lung cancer is the world's leading cause of cancer death and shows strong ancestry
disparities. By sequencing and assembling a large genomic and transcriptomic dataset of …

Single‐cell profiling approaches to probing tumor heterogeneity

BL Khoo, PK Chaudhuri, N Ramalingam… - … journal of cancer, 2016 - Wiley Online Library
Tumor heterogeneity is a major hindrance in cancer classification, diagnosis and treatment.
Recent technological advances have begun to reveal the true extent of its heterogeneity …

Methionine is a metabolic dependency of tumor-initiating cells

Z Wang, LY Yip, JHJ Lee, Z Wu, HY Chew… - Nature medicine, 2019 - nature.com
Understanding cellular metabolism holds immense potential for developing new classes of
therapeutics that target metabolic pathways in cancer. Metabolic pathways are altered in …

[HTML][HTML] Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells

BL Khoo, ME Warkiani, DSW Tan, AAS Bhagat, D Irwin… - PloS one, 2014 - journals.plos.org
Background Circulating tumor cells (CTCs) are cancer cells that can be isolated via liquid
biopsy from blood and can be phenotypically and genetically characterized to provide …

An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells

ME Warkiani, BL Khoo, DSW Tan, AAS Bhagat, WT Lim… - Analyst, 2014 - pubs.rsc.org
The detection and characterization of rare circulating tumor cells (CTCs) from the blood of
cancer patients can potentially provide critical insights into tumor biology and hold great …